ArticleWorld journal of microbiology & biotechnology2022
Engineering laboratory/factory-specific phage-resistant strains of Escherichia coli by mutagenesis and screening.
Article in World journal of microbiology & biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Design and regulation of engineered bacteria for environmental release.Nature microbiology · 2025Review
- The Biological Characteristics ofInternational journal of molecular sciences · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The Escherichia coli (E. coli) has been widely employed in biotechnology industry and academia. However, the bioproduct manufacturing driven by E. coli is prone to the phage contamination. Good laboratory/factory hygiene may decrease but not avoid completely the chances of the phage contamination. The present study aims to resolve this problem by engineering laboratory/factory-specific phage-resistant E. coli strains. By adding a laboratory or factory derived phage into the atmospheric and room temperature plasma mutagenized E. coli, a phage-resistant strain could be generated. Interestingly, the resistant strain exhibited cross-resistance to unencountered phages. When operating the resistant strain in a polluted environment, the phage contamination was largely prevented. There was no significant difference in heterogeneous protein production between the parental strain and the phage-resistant strain. Importantly, it requires only one day to generate the phage-resistant strain. This practical method for engineering laboratory/factory-specific phage-resistant strains may have great potential in resuming E. coli operation in laboratories and factories during phage contamination outbreaks.
Indexed as
Identifiers
35128603What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.